Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7968589 | 1.00 | FURIN (0.56) | FURINLMNAMAPK1HTTL3MBTL1 | |
| SCHEMBL4037961 | 1.00 | FURIN (0.56) | FURINLMNAMAPK1HTTL3MBTL1 | |
| SCHEMBL21239899 | 0.92 | FURIN (0.50) | FURINLMNAMAPK1HTTL3MBTL1 | |
| 2-(1-Phenylethylidene)Hydrazinecarboximidamide SCHEMBL12217973 | 0.88 | FURIN (0.78) | FURINLMNAMAPK1HTTL3MBTL1 | |
| SCHEMBL10802869 | 0.88 | CES2 (0.56) | FURINLMNAMAPK1HTTL3MBTL1 | |
| SCHEMBL12217988 | 0.88 | FURIN (0.58) | FURINLMNAMAPK1HTTL3MBTL1 | |
| SCHEMBL27453647 | 0.88 | FURIN (0.46) | FURINLMNAMAPK1HTTL3MBTL1 | |
| SCHEMBL45278 | 0.80 | LMNA (0.52) | LMNAMAPK1HTTL3MBTL1MAPT | |
| SCHEMBL2736631 | 0.80 | LMNA (0.52) | LMNAMAPK1HTTL3MBTL1MAPT | |
| SCHEMBL3443700 | 0.80 | LMNA (0.52) | LMNAMAPK1HTTL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113933425-B | Method for measuring content of acetophenone azine in plastic, chloroprene rubber or foam | 通标标准技术服务(上海)有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-113933425-A | Method for measuring content of acetophenone azine in plastic, chloroprene rubber and foam | 通标标准技术服务(上海)有限公司 | 2022-01-14 | — | — | CN | claimed |
| JP-4341191-A | — | — | None | — | — | JP | disclosed |
| CN-113933425-B | Method for measuring content of acetophenone azine in plastic, chloroprene rubber or foam | 通标标准技术服务(上海)有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-113933425-B | Method for measuring content of acetophenone azine in plastic, chloroprene rubber or foam | 通标标准技术服务(上海)有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-113933425-B | Method for measuring content of acetophenone azine in plastic, chloroprene rubber or foam | 通标标准技术服务(上海)有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-113933425-A | Method for measuring content of acetophenone azine in plastic, chloroprene rubber and foam | 通标标准技术服务(上海)有限公司 | 2022-01-14 | — | — | CN | disclosed |
| CN-113933425-A | Method for measuring content of acetophenone azine in plastic, chloroprene rubber and foam | 通标标准技术服务(上海)有限公司 | 2022-01-14 | — | — | CN | disclosed |
| EP-2598946-B1 | POLYMERIZABLE COMPOSITION | FUJIFILM CORP (JP) | 2019-04-03 | — | — | EP | disclosed |
| CN-105566227-B | It is a kind of to close the nitrogen activation and method for transformation that object promotes by bivalent rare earth iodine | 复旦大学 | 2019-01-15 | — | — | CN | disclosed |
| US-8895306-B2 | Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | INTREXON CORPORATION (US) | 2014-11-25 | — | — | US | disclosed |
| US-7034184-B2 | Process for producing azine compounds and oxime compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-04-25 | — | — | US | disclosed |
| EP-1342714-B1 | Process for producing azine compounds and oxime compounds | DAICEL CHEM (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-20040171651-A1 | Regulating and tailoring expression levels; such as N-[3-(4-chloro-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-3-ethyl-benzamide | RHEOGENE, INC. (DE CORPORATION) | 2004-09-02 | — | — | US | disclosed |
| US-20030204084-A1 | Process for producing azine compounds and oxime compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-10-30 | — | — | US | disclosed |
| EP-1342714-A1 | Process for producing azine compounds and oxime compounds | Daicel Chemical Industries, Ltd. (JP) | 2003-09-10 | — | — | EP | disclosed |
| US-6229047-B1 | NONLINEAR OPTICAL MATERIAL WHICH IS CHARACTERIZED AS HAVING A HIGH MACROSCOPIC DIPOLE MOMENT ACHIEVED THROUGH PARALLEL PACKING OF DIPOLAR MOLECULES (CRYSTALLINE AZINE BRIDGED DI-ARENE) | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2001-05-08 | — | — | US | disclosed |
| EP-0273274-B1 | Degradation of polyethylene by means of agents generating free radicals | ATOCHEM ELF DEUTSCHLAND (DE) | 2000-07-12 | — | — | EP | disclosed |
| JP-H04341191-A | PRODUCTION OF OPTICALLY ACTIVE ALPHA-METHYLBENZYLAMINE | MERCIAN CORP | 1992-11-27 | — | — | JP | disclosed |
| US-3972876-A | Process for the preparation of symmetrical and unsymmetrical azines and mixtures thereof | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030204084-A1 | Process for producing azine compounds and oxime compounds | CBR1, DAO, ALKBH2 | FURIN 4064/4885LMNA 3050/4885MAPK1 1839/4885 |
| US-20040171651-A1 | Regulating and tailoring expression levels; such as N-[3-(4-chloro-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-3-ethyl-benzamide | NR2E3, ESRRB, NR0B2 | FURIN 4130/4885LMNA 2416/4885MAPK1 3918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.